RYJ

Fund Description
The Invesco Raymond James SB-1 Equity ETF (Fund) is based on the Raymond James SB-1 Equity Index (Index). The Fund will invest at least 80% of its total assets in securities and depositary receipts that comprise the Index. The Index is composed of all equity securities rated Strong Buy 1 by Raymond James & Associates, Inc. The Fund and the Index are rebalanced semi-monthly.
Fund Profile
Fund Name Invesco Raymond James SB-1 Equity ETF
Fund Exchange Ticker RYJ
Fund Sponsor Invesco
Fund ISIN US46137V5223
Net Expense Ratio 0.75 %
Fund Inception Date 19 May 2006
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific Global or ExUS Equities - Quant Strat
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Raymond James SB-1 Equity Index
Index Provider Raymond James
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Funds Combining Developed & Emerging Exposure
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent Not Applicable
Key Statistics
Return As of Date 11 August 2022
Asset Under Management 132.41 Million (USD)
1 Month Total Return 15.88 %
Year To Date Return -4.37 %
1 Year Total Return 2.26 %
3 Year Annualized Total Return 14.71 %
NAV 60.1076
Share Outstanding 2,202,820
Top 10 Holdings (11 August 2022)
Constituent Name Constituent Ticker Constituent Type Weighting
CHEMOCENTRYX INC CCXI EQUI 0.0099922276
TPI COMPOSITES INC TPIC EQUI 0.0085944498
BLOOM ENERGY CORP- A BE EQUI 0.0076890897
EDGIO INC EGIO EQUI 0.0069501996
PING IDENTITY HOLDING CORP PING EQUI 0.0066660486
SUNNOVA ENERGY INTERNATIONAL NOVA EQUI 0.0066294434
RENESOLA LTD-ADR SOL EQUI 0.0063972466
JOUNCE THERAPEUTICS INC JNCE EQUI 0.0063644929
CONSTRUCTION PARTNERS INC-A ROAD EQUI 0.0059289169
BLUEPRINT MEDICINES CORP BPMC EQUI 0.0058538138